Three molecules. Three generations. One evolutionary arc. From semaglutide’s single GLP-1 receptor to tirzepatide’s dual agonism to retatrutide’s triple threat — the structural chemistry behind the GLP-1 revolution, and what each leap forward means for analytical testing.
Read More
BPC-157 is the most discussed peptide in the research community. It also has a synthesis vulnerability hidden in its sequence, a counterion problem that distorts every dose, and a stability paradox that contradicts its own reputation.
Read More
A deep dive into the analytical challenges that make AOD-9604 one of the most difficult peptides to synthesize, store, and verify.
Read More
Most people think about purity as a number on a certificate. Here’s what that number actually means for your biology — from endotoxin cascades to silent heavy metal accumulation.
Read More
When researchers evaluate peptide suppliers, the conversation usually starts with one question: “Where’s the Certificate of Analysis?” Fair question. But it’s incomplete. A COA tells you what a product tested at on a specific day. What it doesn’t tell you is whether the next batch, or the one after that, will meet the same standard. […]
Read More
BAC Water: The Variable Nobody’s Testing Here’s a pattern we see constantly at Vanguard. Someone sends in a peptide for testing. They’re convinced the compound is bunk. The reconstitution went fine, storage was proper, dosing was reasonable. But something’s off. Results aren’t matching expectations. Maybe there’s irritation at the injection site. Maybe the solution went […]
Read More